HPV infection, hrHPV genotypes and multi-infections by age subgroups
| HPV status | Outpatients | Women receiving physical examinations | |||||||
| <21 y | 21–29 y | 30–65 y | >65 y | 21–29 y | 30–65 y | >65 y | |||
| 30–45 y | 46–65 y | 30–45 y | 46–65 y | ||||||
| n=264 | n=4023 | n=15 108 | n=8113 | n=391 | n=495 | n=5178 | n=4249 | n=146 | |
| HPV+ | 111 (42.0) | 937 (23.3) | 3384 (22.4) | 2189 (27.0) | 84 (21.5) | 89 (18.0) | 959 (18.5) | 882 (20.8) | 34 (23.3) |
| Multiple | 49 (18.6) | 301 (7.5) | 746 (4.9) | 627 (7.7) | 36 (9.2) | 17 (3.4) | 187 (3.6) | 213 (5.0) | 15 (10.3) |
| hrHPV | 77 (29.2) | 743 (18.5) | 2572 (17.0) | 1723 (21.2) | 69 (17.6) | 66 (13.3) | 640 (12.4) | 606 (14.3) | 29 (19.9) |
| High-risk HPV* | |||||||||
| 52 | 18 (16.2) | 208 (22.2) | 683 (20.2) | 435 (19.9) | 19 (22.6) | 17 (19.1) | 165 (17.2) | 152 (17.2) | 8 (23.5) |
| 16 | 16 (14.4) | 127 (13.6) | 421 (12.4) | 288 (13.2) | 18 (21.4) | 7 (7.9) | 83 (8.7) | 69 (7.8) | 2 (5.9) |
| 58 | 17 (15.3) | 97 (10.4) | 354 (10.5) | 312 (14.3) | 14 (16.7) | 5 (5.6) | 85 (8.9) | 108 (12.2) | 6 (17.6) |
| 39 | 12 (10.8) | 79 (8.4) | 230 (6.8) | 147 (6.7) | 2 (2.4) | 11 (12.4) | 75 (7.8) | 61 (6.9) | 4 (11.8) |
| 18 | 12 (10.8) | 71 (7.6) | 215 (6.4) | 143 (6.5) | 8 (9.5) | 8 (9.0) | 50 (5.2) | 60 (6.8) | 1 (2.9) |
| 56 | 8 (7.2) | 46 (4.9) | 182 (5.4) | 148 (6.8) | 10 (11.9) | 8 (9.0) | 46 (4.8) | 36 (4.1) | 3 (8.8) |
| 51 | 6 (5.4) | 71 (7.6) | 156 (4.6) | 99 (4.5) | 3 (3.6) | 6 (6.7) | 49 (5.1) | 39 (4.4) | 2 (5.9) |
| 33 | 8 (7.2) | 51 (5.4) | 155 (4.6) | 119 (5.4) | 7 (8.3) | 1 (1.1) | 32 (3.3) | 33 (3.7) | 2 (5.9) |
| 59 | 8 (7.2) | 55 (5.9) | 145 (4.3) | 99 (4.5) | 3 (3.6) | 1 (1.1) | 34 (3.5) | 35 (4.0) | 3 (8.8) |
| 68 | 5 (4.5) | 38 (4.1) | 126 (3.7) | 108 (4.9) | 6 (7.1) | 3 (3.4) | 38 (4.0) | 45 (5.1) | 3 (8.8) |
| 66 | 8 (7.2) | 40 (4.3) | 127 (3.8) | 82 (3.7) | 6 (7.1) | 1 (1.1) | 26 (2.7) | 29 (3.3) | 2 (5.9) |
| 31 | 3 (2.7) | 29 (3.1) | 103 (3.0) | 77 (3.5) | 9 (10.7) | 1 (1.1) | 19 (2.0) | 17 (1.9) | 1 (2.9) |
| 35 | 3 (2.7) | 17 (1.8) | 71 (2.1) | 55 (2.5) | 4 (4.8) | 1 (1.1) | 10 (1.0) | 19 (2.2) | 4 (11.8) |
| 45 | 3 (2.7) | 16 (1.7) | 55 (1.6) | 26 (1.2) | 2 (2.4) | 0 (0.0) | 15 (1.6) | 19 (2.2) | 2 (5.9) |
| Low-risk/undetermined-risk HPV* | |||||||||
| 53 | 8 (7.2) | 59 (6.3) | 232 (6.9) | 168 (7.7) | 5 (6.0) | 8 (9.0) | 104 (10.8) | 88 (10.0) | 3 (8.8) |
| 81† | 4 (7.7) | 34 (7.4) | 111 (6.6) | 91 (8.0) | 2 (4.5) | 7 (10.8) | 56 (8.1) | 50 (8.3) | 2 (11.1) |
| 61 | 6 (5.4) | 48 (5.1) | 218 (6.4) | 176 (8.0) | 7 (8.3) | 4 (4.5) | 61 (6.4) | 90 (10.2) | 1 (2.9) |
| 43† | 5 (9.6) | 27 (5.9) | 88 (5.2) | 72 (6.3) | 4 (9.1) | 3 (4.6) | 48 (6.9) | 32 (5.3) | 2 (11.1) |
| 06 | 23 (20.7) | 63 (6.7) | 128 (3.8) | 66 (3.0) | 3 (3.6) | 4 (4.5) | 34 (3.5) | 22 (2.5) | 1 (2.9) |
| 44 | 6 (5.4) | 29 (3.1) | 131 (3.9) | 68 (3.1) | 3 (3.6) | 3 (3.4) | 44 (4.6) | 47 (5.3) | 0 (0.0) |
| 55 | 4 (3.6) | 18 (1.9) | 100 (3.0) | 87 (4.0) | 2 (2.4) | 2 (2.2) | 46 (4.8) | 50 (5.7) | 1 (2.9) |
| 11 | 11 (9.9) | 45 (4.8) | 75 (2.2) | 51 (2.3) | 4 (4.8) | 2 (2.2) | 14 (1.5) | 10 (1.1) | 1 (2.9) |
| 42 | 5 (4.5) | 12 (1.3) | 72 (2.1) | 66 (3.0) | 0 (0.0) | 2 (2.2) | 23 (2.4) | 18 (2.0) | 0 (0.0) |
| 82 | 3 (2.7) | 33 (3.5) | 85 (2.5) | 38 (1.7) | 3 (3.6) | 2 (2.2) | 19 (2.0) | 11 (1.2) | 2 (5.9) |
| 40 | 4 (3.6) | 20 (2.1) | 44 (1.3) | 30 (1.4) | 1 (1.2) | 1 (1.1) | 13 (1.4) | 18 (2.0) | 0 (0.0) |
| 83 | 0 (0.0) | 11 (1.2) | 27 (0.8) | 27 (1.2) | 0 (0.0) | 0 (0.0) | 10 (1.0) | 10 (1.1) | 0 (0.0) |
| 26 | 1 (0.9) | 0 (0.0) | 6 (0.2) | 8 (0.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| 73‡ | 0 (0.0) | 1 (0.2) | 2 (0.1) | 3 (0.3) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
*Women with multiple HPV infections are counted for each type and are therefore counted more than once.
†For HPV43 and 81, 3373 outpatients had an HPV infection, including 52 cases aged <21 y, 461 cases aged 21–29 y, 1679 cases 30–45 y, 1137 cases aged 46–65 y and 44 cases aged >65 y. Additionally, 1381 women receiving physical examinations had an HPV infection, including 65 cases aged 21–29 y, 692 cases 30–45 y, 606 cases aged 46–65 y and 18 cases aged >65 y.
‡For HPV73, 3915 outpatients had an HPV infection, including 59 cases aged <21 y, 476 cases aged 21–29 y, 1705 cases 30–45 y, 1052 cases aged 46–65 y and 40 cases aged >65 y. Additionally, 583 women receiving physical examinations had an HPV infection, including 24 cases aged 21–29 y, 267 cases 30–45 y, 276 cases aged 46–65 y and 16 cases aged >65 y.
HPV, human papillomavirus; hrHPV, high-riskhuman papillomavirus; y, years.